vs
Side-by-side financial comparison of Laird Superfood, Inc. (LSF) and Spero Therapeutics, Inc. (SPRO). Click either name above to swap in a different company.
Laird Superfood, Inc. is the larger business by last-quarter revenue ($13.3M vs $12.6M, roughly 1.1× Spero Therapeutics, Inc.). Spero Therapeutics, Inc. runs the higher net margin — 250.7% vs -13.2%, a 263.9% gap on every dollar of revenue. On growth, Spero Therapeutics, Inc. posted the faster year-over-year revenue change (24080.8% vs 15.0%). Over the past eight quarters, Spero Therapeutics, Inc.'s revenue compounded faster (847.7% CAGR vs 16.1%).
Laird Superfood, Inc. develops, manufactures and sells a portfolio of plant-based functional superfood products, including premium coffee creamers, hydration blends, nutritional supplements, and plant-powered snacks. It serves health-conscious consumers through direct-to-consumer e-commerce platforms and offline retail partners, mainly operating in the North American market with a focus on sustainably sourced clean ingredients.
LSF vs SPRO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.3M | $12.6M |
| Net Profit | $-1.8M | $31.5M |
| Gross Margin | 34.1% | — |
| Operating Margin | -13.5% | — |
| Net Margin | -13.2% | 250.7% |
| Revenue YoY | 15.0% | 24080.8% |
| Net Profit YoY | -341.4% | 250.9% |
| EPS (diluted) | — | $0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.3M | $12.6M | ||
| Q3 25 | $12.9M | $0 | ||
| Q2 25 | $12.0M | $0 | ||
| Q1 25 | $11.7M | $12.0K | ||
| Q4 24 | $11.6M | $52.0K | ||
| Q3 24 | $11.8M | $65.0K | ||
| Q2 24 | $10.0M | $114.0K | ||
| Q1 24 | $9.9M | $140.0K |
| Q4 25 | $-1.8M | $31.5M | ||
| Q3 25 | $-975.1K | $-7.4M | ||
| Q2 25 | $-362.2K | $-1.7M | ||
| Q1 25 | $-156.2K | $-13.9M | ||
| Q4 24 | $-398.4K | — | ||
| Q3 24 | $-166.1K | $-17.1M | ||
| Q2 24 | $-239.1K | $-17.9M | ||
| Q1 24 | $-1.0M | $-12.7M |
| Q4 25 | 34.1% | — | ||
| Q3 25 | 36.5% | — | ||
| Q2 25 | 39.9% | — | ||
| Q1 25 | 41.9% | — | ||
| Q4 24 | 38.6% | — | ||
| Q3 24 | 43.0% | — | ||
| Q2 24 | 41.8% | — | ||
| Q1 24 | 40.0% | — |
| Q4 25 | -13.5% | — | ||
| Q3 25 | -7.7% | — | ||
| Q2 25 | -3.3% | — | ||
| Q1 25 | -1.9% | -122758.3% | ||
| Q4 24 | -4.1% | — | ||
| Q3 24 | -2.3% | -28604.6% | ||
| Q2 24 | -3.4% | -16720.2% | ||
| Q1 24 | -11.0% | -9987.1% |
| Q4 25 | -13.2% | 250.7% | ||
| Q3 25 | -7.6% | — | ||
| Q2 25 | -3.0% | — | ||
| Q1 25 | -1.3% | -115550.0% | ||
| Q4 24 | -3.4% | — | ||
| Q3 24 | -1.4% | -26380.0% | ||
| Q2 24 | -2.4% | -15668.4% | ||
| Q1 24 | -10.3% | -9049.3% |
| Q4 25 | — | $0.56 | ||
| Q3 25 | — | $-0.13 | ||
| Q2 25 | — | $-0.03 | ||
| Q1 25 | — | $-0.25 | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-0.32 | ||
| Q2 24 | — | $-0.33 | ||
| Q1 24 | — | $-0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.1M | $40.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $11.5M | $59.0M |
| Total Assets | $19.2M | $68.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.1M | $40.3M | ||
| Q3 25 | $5.1M | $48.6M | ||
| Q2 25 | $3.9M | $31.2M | ||
| Q1 25 | $7.0M | $48.9M | ||
| Q4 24 | $8.3M | $52.9M | ||
| Q3 24 | $7.9M | $76.3M | ||
| Q2 24 | $7.6M | $63.5M | ||
| Q1 24 | $7.1M | $82.3M |
| Q4 25 | $11.5M | $59.0M | ||
| Q3 25 | $12.8M | $26.5M | ||
| Q2 25 | $13.4M | $32.8M | ||
| Q1 25 | $13.3M | $33.8M | ||
| Q4 24 | $13.2M | $46.1M | ||
| Q3 24 | $13.1M | $65.5M | ||
| Q2 24 | $12.6M | $80.5M | ||
| Q1 24 | $12.7M | $96.2M |
| Q4 25 | $19.2M | $68.9M | ||
| Q3 25 | $18.9M | $54.2M | ||
| Q2 25 | $20.4M | $62.1M | ||
| Q1 25 | $21.5M | $77.7M | ||
| Q4 24 | $19.3M | $110.5M | ||
| Q3 24 | $18.8M | $135.2M | ||
| Q2 24 | $18.0M | $149.9M | ||
| Q1 24 | $17.6M | $167.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $68.4K | $-8.4M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | -0.26× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $68.4K | $-8.4M | ||
| Q3 25 | $1.2M | $17.4M | ||
| Q2 25 | $-2.8M | $-17.7M | ||
| Q1 25 | $-1.3M | $-4.0M | ||
| Q4 24 | $339.2K | $-23.4M | ||
| Q3 24 | $305.8K | $12.8M | ||
| Q2 24 | $642.7K | $-18.7M | ||
| Q1 24 | $-422.3K | $5.9M |
| Q4 25 | — | -0.26× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LSF
| Wholesale | $7.0M | 52% |
| Coffee Tea And Hot Chocolate Products | $4.4M | 33% |
| Hydration And Beverage Enhancing Supplements | $1.6M | 12% |
| Other | $352.6K | 3% |
SPRO
Segment breakdown not available.
